Marshall Wace’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,182
| Closed | -$308K | – | 2616 |
|
|
2025
Q1 | $308K | Buy |
+9,182
| New | +$308K | ﹤0.01% | 2139 |
|
|
2024
Q3 | – | Sell |
-141,204
| Closed | -$6.32M | – | 2370 |
|
|
2024
Q2 | $6.32M | Buy |
+141,204
| New | +$6.32M | 0.01% | 830 |
|
|
2023
Q4 | – | Sell |
-29,500
| Closed | -$877K | – | 1902 |
|
|
2023
Q3 | $877K | Buy |
+29,500
| New | +$877K | ﹤0.01% | 1298 |
|
|
2022
Q1 | – | Sell |
-445
| Closed | -$12K | – | 2724 |
|
|
2021
Q4 | $12K | Buy |
+445
| New | +$12K | ﹤0.01% | 3033 |
|
|
2020
Q2 | – | Sell |
-4,246
| Closed | -$62K | – | 1580 |
|
|
2020
Q1 | $62K | Buy |
+4,246
| New | +$62K | ﹤0.01% | 1383 |
|
|
2019
Q4 | – | Sell |
-55,112
| Closed | -$829K | – | 1702 |
|
|
2019
Q3 | $829K | Buy |
55,112
+20,874
| +61% | +$314K | 0.01% | 949 |
|
|
2019
Q2 | $857K | Buy |
34,238
+176
| +0.5% | +$4.41K | 0.01% | 941 |
|
|
2019
Q1 | $775K | Buy |
+34,062
| New | +$775K | 0.01% | 1005 |
|